We found that TGF‐β1 blockade also decreased the mRNA expression of non‐canonical signaling pathways, including RhoA, MAPK, Akt and NFκB, suggesting that both canonical and non‐canonical signaling pathways regulate responses to increased TGF‐β1 expression in lymphedema. Here, TGFB1 is linked to lymphedema.